Relaxin as novel strategy in the management of atrial fibrillation: potential roles and future perspectives

Int J Cardiol. 2014 Feb 15;171(3):e72-3. doi: 10.1016/j.ijcard.2013.11.103. Epub 2013 Dec 6.

Authors

Zhiqiang Zhao¹, Chee Yuan Ng², Tong Liu¹, Hongmin Li¹, Guangping Li³

Affiliations

¹ Department of Cardiology, Tianjin Institute of Cardiology, Second Hospital of Tianjin Medical University, Tianjin 300211, People's Republic of China.
² Department of Cardiology, Loma Linda University Medical Center, CA, United States.
³ Department of Cardiology, Tianjin Institute of Cardiology, Second Hospital of Tianjin Medical University, Tianjin 300211, People's Republic of China. Electronic address: [email protected].

PMID: 24373631
DOI: 10.1016/j.ijcard.2013.11.103

No abstract available

Keywords: Atrial fibrillation; Fibrosis; Inflammation; Oxidative stress; Relaxin.

Publication types

Letter
Review

MeSH terms

Animals
Atrial Fibrillation / diagnosis*
Atrial Fibrillation / drug therapy*
Disease Management
Forecasting
Humans
Relaxin / therapeutic use*

Substances

Relaxin